loader
Peritoneal Surface Malignancy

Advanced Peritoneal Cancer Management with CRS & HIPEC in Pune

Timely intervention, precise surgery, and compassionate care for peritoneal cancers with Dr. Snita Sinukumar.

Peritoneal Cancer Treatment Pune
Shape Image

Leading-Edge Surgical Oncology for Peritoneal Disease

Peritoneal surface malignancy occurs when cancer spreads within the abdominal cavity, affecting the peritoneum that lines the organs. Early evaluation and precise surgical intervention are vital for optimal outcomes.

At Remedium Superspeciality Clinic, we provide comprehensive care for peritoneal cancers, including:

  • Precision-guided surgical oncology
  • CRS with HIPEC for advanced abdominal malignancies
  • Robotic-assisted surgery when appropriate
  • Personalised treatment planning and structured follow-up

What is Peritoneal Surface Malignancy?

Peritoneal surface malignancy occurs when cancer spreads across the peritoneum, the lining of the abdominal organs. It can originate from ovarian, colorectal, stomach, appendix, or primary peritoneal cancers.

Warning signs include abdominal swelling, fluid buildup (ascites), digestive issues, or unexplained weight loss. Early evaluation by a specialist improves treatment outcomes.

CRS & HIPEC Surgery: Life-Changing Precision for Peritoneal Cancers

Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a game-changing treatment for peritoneal surface malignancies. This advanced procedure removes all visible tumors from the abdominal cavity, including affected peritoneal lining and involved organs when needed, aiming for complete tumor clearance.

Immediately after surgery, HIPEC delivers heated chemotherapy directly into the abdomen, targeting hidden cancer cells with unmatched precision. The heat boosts effectiveness while reducing side effects, giving patients the best chance for long-term control.

Dr. Snita Sinu Kumar, one of India’s few CRS & HIPEC-trained surgeons, offers this specialised treatment at Apollo Hospitals, Pune, blending surgical expertise with personalised care for optimal outcomes.

Why Early Evaluation Matters

Timely assessment is critical because peritoneal cancers often present with subtle or non-specific symptoms. Early detection allows:

  • Optimised surgical outcomes
  • Higher chance of complete tumor removal
  • Reduced risk of recurrence
  • Personalised treatment planning

Who Benefits from CRS & HIPEC?

Patients with peritoneal surface involvement from cancers such as:

  • Ovarian cancer
  • Colorectal cancer
  • Gastric (stomach) cancer
  • Appendix cancer
  • Primary peritoneal tumors

Early referral to a specialist improves the potential for long-term disease control.

About Dr. Snita Sinukumar
Shape Image
Why Choose

Dr. Snita Sinukumar for Peritoneal Cancer Care?

  • Extensive expertise in peritoneal and complex abdominal cancers
  • Individualised, evidence-based treatment plans for each patient
  • Advanced CRS & HIPEC surgical skills
  • Compassionate, patient-centred approach throughout the journey
  • Accessible care at Kharadi and Apollo Hospitals, Pune
Book an Appointment
FAQs

Frequently Asked Questions

In select patients, CRS with HIPEC can control disease long-term, especially if cancer is confined, complete tumor removal is possible, and overall health supports surgery.
Yes, it’s a complex procedure requiring meticulous planning, long operating time, and intensive monitoring, performed by experienced surgeons for optimal outcomes.
Recovery varies by disease extent and surgery length. Hospital stay is usually 7–14 days, with gradual return to normal activity over several weeks.
Patients with peritoneal carcinomatosis, advanced ovarian, colon, appendix, or selected gastric cancers may benefit from this specialised surgical treatment.
HIPEC delivers heated chemotherapy directly to the abdominal cavity, targeting residual cancer cells with precision while minimising systemic side effects.
Advanced CRS and HIPEC surgery is performed in a fully equipped tertiary care hospital with a dedicated surgical oncology team.
Early evaluation is critical. Prompt consultation improves treatment outcomes and ensures eligibility for complete cytoreduction and HIPEC therapy.